GlassScriptPhysician profile
Daniel G Reznicek
NPI 1134414477
$11,344.31
in general payments reported to CMS, 2019-2025
57 companies · $2,768 in 2025
The $2,768 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,101 · 2020: $905 · 2021: $748 · 2022: $1,729 · 2023: $1,495 · 2024: $1,598 · 2025: $2,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,258 · Travel and Lodging: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,258.37 |
| Travel and Lodging | $602.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,874.89 | 2021-2025 | Altaviva, Interstim |
| Neotract INC. | $1,734.32 | 2019-2020 | |
| Boston Scientific Corporation | $1,295.72 | 2019-2025 | Lithovue, Ams 700, Rezum Generator |
| Janssen Biotech, INC. | $784.44 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $501.33 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $485.37 | 2019-2025 | Provenge |
| Abbvie INC. | $467.52 | 2019-2025 | |
| Astellas Pharma US INC | $365.71 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Pfizer INC. | $258.73 | 2019-2025 | |
| Accord Healthcare, INC. | $255.11 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $216.26 | 2019-2024 | Aveed, Xiaflex |
| Coloplast Corp | $178.33 | 2019-2025 | Titan |
| Rochester Medical Corporation | $165.45 | 2022 | |
| Tempus Ai, INC | $159.36 | 2024-2025 | Xt Cdx |
| Progenics Pharmaceuticals, INC. | $152.76 | 2021-2025 | Pylarify |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $147.14 | 2021-2023 | Nocdurna, Tlando, Xyosted |
| Urogen Pharma, INC. | $136.91 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $135.57 | 2022-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Ferring Pharmaceuticals INC. | $120.83 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $116.19 | 2019-2024 | |
| Myriad Genetic Laboratories, INC. | $112.91 | 2021-2024 | Prolaris, Precisetumor |
| Endo USA, INC. | $111.01 | 2024-2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $100.53 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $92.94 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Myovant Sciences INC. | $84.73 | 2021-2022 | |
| Tolmar, INC. | $79.93 | 2023-2025 | Jatenzo, Eligard |
| C. R. Bard, INC. & Subsidiaries | $79.63 | 2023-2024 | Bard Urinary Drainage Bag |
| Olympus America INC. | $77.88 | 2024-2025 | Itind System, Soltive |
| 180 Medical, INC. | $76.69 | 2020-2025 | Cure Catheter, Gentlecath Glide |
| Teleflex LLC | $71.19 | 2021-2025 | Urolift |
| Sun Pharmaceutical Industries INC. | $66.81 | 2022-2023 | Yonsa |
| Novartis Pharmaceuticals Corporation | $63.24 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $60.04 | 2019-2020 | |
| Medtronic USA, INC. | $57.95 | 2019-2020 | |
| Convatec INC. | $53.66 | 2019-2022 | |
| Travere Therapeutics, INC. | $53.60 | 2019-2022 | |
| Procept Biorobotics Corporation | $48.93 | 2019-2024 | Aquabeam System |
| Axonics, INC. | $46.67 | 2021-2022 | |
| Therapeuticsmd, INC. | $41.06 | 2019-2020 | |
| Telix Pharmaceuticals | $39.09 | 2024-2025 | Illuccix |
| Allergan, INC. | $38.14 | 2019 | |
| Becton, Dickinson and Company | $37.86 | 2024 | Bard Urinary Drainage Bag |
| Abc Home Medical Supply, INC. | $37.35 | 2022-2024 | |
| Urovant Sciences INC | $26.80 | 2022 | |
| Bioprotect Medical, INC. | $25.04 | 2025 | Bioprotect Balloon Implant System |
| Immunitybio, INC. | $24.91 | 2025 | |
| Calyxo, INC. | $22.54 | 2024 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $22.32 | 2022 | |
| Trevena, INC. | $19.50 | 2022 | |
| Profound Medical Corp. | $16.78 | 2022 | |
| Ambu INC. | $15.89 | 2022 | |
| Amgen INC. | $15.67 | 2019 | |
| Photocure INC | $15.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.91 | 2023 | Seglentis |
| Angiodynamics, INC. | $14.57 | 2023 | Nanoknife |
| Alnylam Pharmaceuticals INC. | $13.27 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Reznicek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.